Evidence map›Paper›PMID 25254513›Full record

ArticlePLoS neglected tropical diseases2014

Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins.

Daniel Wan, Fernanda Ludolf, Daniel G W Alanine, Owen Stretton, Eman Ali Ali, Nafal Al-Barwary, Xiaowei Wang, Michael J Doenhoff, Adriano Mari, Colin M Fitzsimmons and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Allergen skin test reactivity and asthma are inversely associated with ratios of IgG4/IgE and total IgE/allergen-specific IgE in Ugandan communities.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Daniel WanDivision of Molecular and Cellular Science, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom; School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.
Fernanda LudolfGenomics and Computational Biology Group, Centro de Pesquisas René Rachou, National Institute of Science and Technology in Tropical Diseases, Fundação Oswaldo Cruz - FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil.
Daniel G W AlanineDivision of Molecular and Cellular Science, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom; School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.
Owen StrettonDivision of Molecular and Cellular Science, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
Eman Ali AliDivision of Molecular and Cellular Science, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
Nafal Al-BarwaryDivision of Molecular and Cellular Science, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
Xiaowei WangSchool of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.
Michael J DoenhoffSchool of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Adriano MariCenter for Molecular Allergology, IDI-IRCCS, Rome, Italy; Associated Centres for Molecular Allergology, Rome, Italy.
Colin M FitzsimmonsDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
David W DunneDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Ryosuke NakamuraDivision of Medicinal Safety Science, National Institute of Health Sciences, Setagaya-ku, Tokyo, Japan.
Guilherme C OliveiraGenomics and Computational Biology Group, Centro de Pesquisas René Rachou, National Institute of Science and Technology in Tropical Diseases, Fundação Oswaldo Cruz - FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil.
Marcos J C AlcocerSchool of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, United Kingdom.
Franco H FalconeDivision of Molecular and Cellular Science, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.
University of Nottingham · GBFundação Oswaldo Cruz · BRUniversity of Cambridge · GBIstituti di Ricovero e Cura a Carattere Scientifico · ITNational Institute of Health Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParasite-specific IgE is thought to correlate with protection against Schistosoma mansoni infection or re-infection. Only a few molecular targets of the IgE response in S. mansoni infection have been characterised. A better insight into the basic mechanisms of anti-parasite immunity could be gained from a genome-wide characterisation of such S. mansoni allergens. This would have repercussions on our understanding of allergy and the development of safe and efficacious vaccinations against helminthic parasites. METHODOLOGY/PRINCIPAL

findingsA complete medium- to high-throughput amenable workflow, including important quality controls, is described, which enables the rapid translation of S. mansoni proteins using wheat germ lysate and subsequent assessment of potential allergenicity with a humanised Rat Basophilic Leukemia (RBL) reporter cell line. Cell-free translation is completed within 90 minutes, generating sufficient amounts of parasitic protein for rapid screening of allergenicity without any need for purification. Antigenic integrity is demonstrated using Western Blotting. After overnight incubation with infected individuals' serum, the RS-ATL8 reporter cell line is challenged with the complete wheat germ translation mixture and Luciferase activity measured, reporting cellular activation by the suspected allergen. The suitability of this system for characterization of novel S. mansoni allergens is demonstrated using well characterised plant and parasitic allergens such as Par j 2, SmTAL-1 and the IgE binding factor IPSE/alpha-1, expressed in wheat germ lysates and/or E. coli. SmTAL-1, but not SmTAL2 (used as a negative control), was able to activate the basophil reporter cell line. CONCLUSION/SIGNIFICANCE: This method offers an accessible way for assessment of potential allergenicity of anti-helminthic vaccine candidates and is suitable for medium- to high-throughput studies using infected individual sera. It is also suitable for the study of the basis of allergenicity of helminthic proteins.

Indexed as

AdolescentAdultAllergensAnimalsAntigens, HelminthCell Line, TumorChildHelminth ProteinsHumansMaleProtozoan VaccinesRatsSchistosoma mansoniYoung AdultAllergensAntigens, HelminthHelminth ProteinsProtozoan Vaccines

Identifiers

PMID25254513
PMCPMC4177753
OpenAlexW2050762758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.